首页 > 最新文献

Clinical medicine insights. Women's health最新文献

英文 中文
De materia medica versus codex alimentarius for the reinforcement of the gynecologic immune system: the case of endometriosis. 增强妇科免疫系统的中药与食疗:子宫内膜异位症病例。
Pub Date : 2013-01-30 eCollection Date: 2013-01-01 DOI: 10.4137/CMWH.S11214
Simon Vassiliadis

Since the first Pharmacopoeia under the title "De Materia Medica," the importance of the utilization of plants and herbs has been an invaluable medicinal tool successfully employed for strengthening the immune system for combating a number of diseases in general, or assisting fertility and reproductive issues in particular. The beneficial use of herbal extracts, constituting the basis of modern medicines, is lately under the shadow of Codex Alimentarius that threatens, if not properly applied, serious immunity features rendering the host defenseless for intercepting harmful invaders, one of which is the mesenchymal endometriotic stem cell causing endometriosis.

自第一部名为《本草纲目》的药典问世以来,利用植物和草药的重要性一直是一种宝贵的医疗工具,成功地用于增强免疫系统,对抗许多疾病,特别是帮助生育和生殖问题。草药提取物是现代药物的基础,其有益用途最近受到食品法典委员会的阴影,如果应用不当,它会威胁到严重的免疫功能,使宿主无法抵御有害入侵者,其中之一是引起子宫内膜异位症的间充质子宫内膜异位干细胞。
{"title":"De materia medica versus codex alimentarius for the reinforcement of the gynecologic immune system: the case of endometriosis.","authors":"Simon Vassiliadis","doi":"10.4137/CMWH.S11214","DOIUrl":"10.4137/CMWH.S11214","url":null,"abstract":"<p><p>Since the first Pharmacopoeia under the title \"De Materia Medica,\" the importance of the utilization of plants and herbs has been an invaluable medicinal tool successfully employed for strengthening the immune system for combating a number of diseases in general, or assisting fertility and reproductive issues in particular. The beneficial use of herbal extracts, constituting the basis of modern medicines, is lately under the shadow of Codex Alimentarius that threatens, if not properly applied, serious immunity features rendering the host defenseless for intercepting harmful invaders, one of which is the mesenchymal endometriotic stem cell causing endometriosis. </p>","PeriodicalId":90142,"journal":{"name":"Clinical medicine insights. Women's health","volume":"6 ","pages":"31-5"},"PeriodicalIF":0.0,"publicationDate":"2013-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/CMWH.S11214","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32204978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Android shape independent of aerobic fitness: a risk factor for low bone mineral content in overweight and obese latina women. 与有氧健身无关的 Android 体型:超重和肥胖拉丁裔女性骨矿物质含量低的风险因素。
Pub Date : 2013-01-29 eCollection Date: 2013-01-01 DOI: 10.4137/CMWH.S10979
Afrooz Afghani

Objective: The link between central adiposity and osteopenia has not been extensively studied in Latina women. In particular, the association between abdominal weight and bone mineral content (BMC) and bone mineral density (BMD), independent of total weight and aerobic capacity, remains uncertain, especially in overweight and obese individuals.

Methods: Trunk weight, total body fat mass, fat-free mass, BMC, and BMD of 33 premenopausal Latina women age 22 to 51 years from Los Angeles, California were measured using dual-energy X-ray absorptiometry (DXA). Waist circumference (WC) was measured without clothing at the smallest circumference of the torso. Peak aerobic capacity (peak VO2) was determined by treadmill ergometry with direct measurement of oxygen consumption.

Results: Partial correlations controlling for total body fat mass, fat-free mass, and peak VO2 revealed a significant inverse relationship between BMC and WC (r = -0.54, P < 0.05) but not between BMD and WC (r = -0.18, P = 0.41). Similarly, while controlling for total body fat, fat-free mass, and peak VO2, BMC was inversely associated with trunk fat (r = -0.75, P < 0.001), with trunk lean (r = -0.61, P < 0.05) and with total trunk weight (r = -0.75, P < 0.001); results were non-significant for BMD. When these analyses were repeated separately in overweight (n = 10) versus in the obese (n = 18) women, inverse relationships between BMC and trunk fat as well as between BMC and total trunk weight became stronger in the obese compared with the overweight women.

Conclusion: Although general obesity may prevent osteoporosis, these findings suggest that abdominal obesity (ie, trunk weight) specifically and independently may adversely influence bone mass.

研究目的关于拉丁裔女性中央脂肪与骨质疏松之间的关系,尚未进行广泛研究。特别是,腹部重量与骨矿物质含量(BMC)和骨矿物质密度(BMD)之间的关系(与总重量和有氧运动能力无关)仍不确定,尤其是在超重和肥胖者中:方法:使用双能 X 射线吸收仪(DXA)测量了加利福尼亚州洛杉矶市 33 名 22 至 51 岁绝经前拉丁裔女性的躯干重量、总脂肪量、无脂肪量、BMC 和 BMD。腰围(WC)是在不穿衣服的情况下测量的躯干最小周长。峰值有氧能力(峰值 VO2)通过跑步机测力计测定,并直接测量耗氧量:结果:控制身体总脂肪量、无脂肪量和峰值 VO2 的部分相关性表明,BMC 与 WC 之间存在显著的反向关系(r = -0.54,P < 0.05),但 BMD 与 WC 之间没有显著的反向关系(r = -0.18,P = 0.41)。同样,在控制体脂总量、无脂质量和峰值 VO2 的情况下,BMC 与躯干脂肪(r = -0.75,P <0.001)、躯干瘦肉(r = -0.61,P <0.05)和躯干总重量(r = -0.75,P <0.001)呈反向关系;BMD 的结果不显著。当分别对超重(10 人)和肥胖(18 人)妇女进行上述分析时,肥胖妇女的 BMC 与躯干脂肪以及 BMC 与躯干总重量之间的反比关系比超重妇女更强:结论:虽然全身肥胖可能会预防骨质疏松症,但这些研究结果表明,腹部肥胖(即躯干重量)可能会单独对骨质量产生不利影响。
{"title":"Android shape independent of aerobic fitness: a risk factor for low bone mineral content in overweight and obese latina women.","authors":"Afrooz Afghani","doi":"10.4137/CMWH.S10979","DOIUrl":"10.4137/CMWH.S10979","url":null,"abstract":"<p><strong>Objective: </strong>The link between central adiposity and osteopenia has not been extensively studied in Latina women. In particular, the association between abdominal weight and bone mineral content (BMC) and bone mineral density (BMD), independent of total weight and aerobic capacity, remains uncertain, especially in overweight and obese individuals.</p><p><strong>Methods: </strong>Trunk weight, total body fat mass, fat-free mass, BMC, and BMD of 33 premenopausal Latina women age 22 to 51 years from Los Angeles, California were measured using dual-energy X-ray absorptiometry (DXA). Waist circumference (WC) was measured without clothing at the smallest circumference of the torso. Peak aerobic capacity (peak VO2) was determined by treadmill ergometry with direct measurement of oxygen consumption.</p><p><strong>Results: </strong>Partial correlations controlling for total body fat mass, fat-free mass, and peak VO2 revealed a significant inverse relationship between BMC and WC (r = -0.54, P < 0.05) but not between BMD and WC (r = -0.18, P = 0.41). Similarly, while controlling for total body fat, fat-free mass, and peak VO2, BMC was inversely associated with trunk fat (r = -0.75, P < 0.001), with trunk lean (r = -0.61, P < 0.05) and with total trunk weight (r = -0.75, P < 0.001); results were non-significant for BMD. When these analyses were repeated separately in overweight (n = 10) versus in the obese (n = 18) women, inverse relationships between BMC and trunk fat as well as between BMC and total trunk weight became stronger in the obese compared with the overweight women.</p><p><strong>Conclusion: </strong>Although general obesity may prevent osteoporosis, these findings suggest that abdominal obesity (ie, trunk weight) specifically and independently may adversely influence bone mass.</p>","PeriodicalId":90142,"journal":{"name":"Clinical medicine insights. Women's health","volume":"6 ","pages":"25-30"},"PeriodicalIF":0.0,"publicationDate":"2013-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941180/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32204977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abnormal bleeding during menopause hormone therapy: insights for clinical management. 绝经期激素治疗中的异常出血:临床处理的见解。
Pub Date : 2013-01-23 eCollection Date: 2013-01-01 DOI: 10.4137/CMWH.S10483
Sebastião Freitas de Medeiros, Márcia Marly Winck Yamamoto, Jacklyne Silva Barbosa

Objective: Our objective was to review the involved mechanisms and propose actions for controlling/treating abnormal uterine bleeding during climacteric hormone therapy.

Methods: A systemic search of the databases SciELO, MEDLINE, and Pubmed was performed for identifying relevant publications on normal endometrial bleeding, abnormal uterine bleeding, and hormone therapy bleeding.

Results: Before starting hormone therapy, it is essential to exclude any abnormal organic condition, identify women at higher risk for bleeding, and adapt the regimen to suit eachwoman's characteristics. Abnormal bleeding with progesterone/progestogen only, combined sequential, or combined continuous regimens may be corrected by changing the progestogen, adjusting the progestogen or estrogen/progestogen doses, or even switching the initial regimen to other formulation.

Conclusion: To diminish the occurrence of abnormal bleeding during hormone therapy (HT), it is important to tailor the regimen to the needs of individual women and identify those with higher risk of bleeding. The use of new agents as adjuvant therapies for decreasing abnormal bleeding in women on HT awaits future studies.

目的:综述更年期激素治疗过程中子宫异常出血的发生机制,并提出控制/治疗子宫异常出血的措施。方法:系统检索SciELO、MEDLINE和Pubmed数据库,确定正常子宫内膜出血、异常子宫出血和激素治疗出血的相关文献。结果:在开始激素治疗之前,必须排除任何异常的器质性疾病,确定出血风险较高的妇女,并根据每个妇女的特点调整方案。单用黄体酮/黄体酮、联合序贯或联合连续治疗方案的异常出血可以通过改变黄体酮、调整黄体酮或雌激素/黄体酮剂量,甚至将初始方案改为其他配方来纠正。结论:为减少激素治疗中异常出血的发生,应根据患者个体的需要制定相应的治疗方案,识别出血风险较高的患者。使用新的药物作为辅助治疗来减少HT治疗妇女的异常出血有待于进一步的研究。
{"title":"Abnormal bleeding during menopause hormone therapy: insights for clinical management.","authors":"Sebastião Freitas de Medeiros,&nbsp;Márcia Marly Winck Yamamoto,&nbsp;Jacklyne Silva Barbosa","doi":"10.4137/CMWH.S10483","DOIUrl":"https://doi.org/10.4137/CMWH.S10483","url":null,"abstract":"<p><strong>Objective: </strong>Our objective was to review the involved mechanisms and propose actions for controlling/treating abnormal uterine bleeding during climacteric hormone therapy.</p><p><strong>Methods: </strong>A systemic search of the databases SciELO, MEDLINE, and Pubmed was performed for identifying relevant publications on normal endometrial bleeding, abnormal uterine bleeding, and hormone therapy bleeding.</p><p><strong>Results: </strong>Before starting hormone therapy, it is essential to exclude any abnormal organic condition, identify women at higher risk for bleeding, and adapt the regimen to suit eachwoman's characteristics. Abnormal bleeding with progesterone/progestogen only, combined sequential, or combined continuous regimens may be corrected by changing the progestogen, adjusting the progestogen or estrogen/progestogen doses, or even switching the initial regimen to other formulation.</p><p><strong>Conclusion: </strong>To diminish the occurrence of abnormal bleeding during hormone therapy (HT), it is important to tailor the regimen to the needs of individual women and identify those with higher risk of bleeding. The use of new agents as adjuvant therapies for decreasing abnormal bleeding in women on HT awaits future studies.</p>","PeriodicalId":90142,"journal":{"name":"Clinical medicine insights. Women's health","volume":"6 ","pages":"13-24"},"PeriodicalIF":0.0,"publicationDate":"2013-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/CMWH.S10483","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32204976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Clinical utility of aromatase inhibitors as adjuvant treatment in postmenopausal early breast cancer. 芳香酶抑制剂作为绝经后早期乳腺癌辅助治疗的临床应用。
Pub Date : 2013-01-22 eCollection Date: 2013-01-01 DOI: 10.4137/CMWH.S8692
Arturo Loaiza-Bonilla, Francisco Socola, Stefan Glück

Breast cancer is the most frequently diagnosed malignancy in women, with over 200,000 new cases diagnosed each year. Adjuvant systemic endocrine therapy has demonstrated its benefits in reducing the risk of occult micro metastatic infiltration by preventing breast cancer cells from receiving endogenous estrogen stimulation. Initial adjuvant treatment with an aromatase inhibitor (AI) is considered the standard of care for most postmenopausal women with node-positive and high-risk node-negative estrogen receptor (ER)-positive breast cancer. Aromatase inhibitors (AIs) are generally preferred over tamoxifen due to their effectiveness in preventing breast cancer recurrence post surgery and when tamoxifen side effects are to be avoided. When compared with tamoxifen, AIs are associated with significantly improved disease-free survival, however no OS advantage has been noted. Potential toxicities such as bone loss, dyslipidemia, musculoskeletal and cardiovascular health issues should be taken into consideration when AIs are to be used.

乳腺癌是妇女中最常见的恶性肿瘤,每年新诊断的病例超过20万例。辅助全身内分泌治疗已证明其益处,通过防止乳腺癌细胞接受内源性雌激素刺激来降低隐性微转移浸润的风险。芳香化酶抑制剂(AI)的初始辅助治疗被认为是大多数绝经后淋巴结阳性和高危淋巴结阴性雌激素受体(ER)阳性乳腺癌妇女的标准治疗。芳香酶抑制剂(AIs)通常优于他莫昔芬,因为它们可以有效地预防乳腺癌术后复发,并且可以避免他莫昔芬的副作用。与他莫昔芬相比,AIs与显著改善的无病生存相关,但未发现OS优势。使用人工智能时,应考虑到潜在的毒性,如骨质流失、血脂异常、肌肉骨骼和心血管健康问题。
{"title":"Clinical utility of aromatase inhibitors as adjuvant treatment in postmenopausal early breast cancer.","authors":"Arturo Loaiza-Bonilla,&nbsp;Francisco Socola,&nbsp;Stefan Glück","doi":"10.4137/CMWH.S8692","DOIUrl":"https://doi.org/10.4137/CMWH.S8692","url":null,"abstract":"<p><p>Breast cancer is the most frequently diagnosed malignancy in women, with over 200,000 new cases diagnosed each year. Adjuvant systemic endocrine therapy has demonstrated its benefits in reducing the risk of occult micro metastatic infiltration by preventing breast cancer cells from receiving endogenous estrogen stimulation. Initial adjuvant treatment with an aromatase inhibitor (AI) is considered the standard of care for most postmenopausal women with node-positive and high-risk node-negative estrogen receptor (ER)-positive breast cancer. Aromatase inhibitors (AIs) are generally preferred over tamoxifen due to their effectiveness in preventing breast cancer recurrence post surgery and when tamoxifen side effects are to be avoided. When compared with tamoxifen, AIs are associated with significantly improved disease-free survival, however no OS advantage has been noted. Potential toxicities such as bone loss, dyslipidemia, musculoskeletal and cardiovascular health issues should be taken into consideration when AIs are to be used. </p>","PeriodicalId":90142,"journal":{"name":"Clinical medicine insights. Women's health","volume":"6 ","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2013-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/CMWH.S8692","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32204974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Developing an alcohol education leaflet for pregnant women using qualitative and quantitative data. 利用定性和定量数据为孕妇制作酒精教育小册子。
Pub Date : 2011-02-28 eCollection Date: 2011-01-01 DOI: 10.4137/CMWH.S6541
Noriko Sudo

Objective: This article summarizes the process of developing and evaluating a series of alcohol educational leaflets with pregnant women.

Methods: Four group interviews were conducted with a total of 33 pregnant women.

Results: The copy, font, and color should be tailored to pregnant women. Scientifically compelling information was preferred; the use of too many colors and objects was considered distracting and reducing the seriousness of the information. The facts presented through a patient's photo of fetal alcohol syndrome and a graph impressed the participants, since they were tired of the illustrations found in many other materials. Pregnant women who are interested and motivated to learn about alcohol consumption valued the quality of the information, rather than visual appeal.

Conclusions: Testing a draft leaflet with the target population before final development and dissemination is a critical component of an educational outreach effort. Incorporating feedback can help enhance the quality of the end product.

目的:综述了一系列孕妇酒精教育宣传单的制作和评价过程。方法:采用4组访谈法对33例孕妇进行调查。结果:文案、字体、颜色应适合孕妇。科学上令人信服的信息是首选;使用太多的颜色和物体被认为会分散注意力,降低信息的严肃性。通过胎儿酒精综合症患者的照片和图表展示的事实给参与者留下了深刻的印象,因为他们厌倦了在许多其他材料中找到的插图。有兴趣并有动力了解酒精消费的孕妇更看重信息的质量,而不是视觉吸引力。结论:在最后编制和散发之前,在目标人群中测试传单草稿是教育推广工作的关键组成部分。结合反馈可以帮助提高最终产品的质量。
{"title":"Developing an alcohol education leaflet for pregnant women using qualitative and quantitative data.","authors":"Noriko Sudo","doi":"10.4137/CMWH.S6541","DOIUrl":"https://doi.org/10.4137/CMWH.S6541","url":null,"abstract":"<p><strong>Objective: </strong>This article summarizes the process of developing and evaluating a series of alcohol educational leaflets with pregnant women.</p><p><strong>Methods: </strong>Four group interviews were conducted with a total of 33 pregnant women.</p><p><strong>Results: </strong>The copy, font, and color should be tailored to pregnant women. Scientifically compelling information was preferred; the use of too many colors and objects was considered distracting and reducing the seriousness of the information. The facts presented through a patient's photo of fetal alcohol syndrome and a graph impressed the participants, since they were tired of the illustrations found in many other materials. Pregnant women who are interested and motivated to learn about alcohol consumption valued the quality of the information, rather than visual appeal.</p><p><strong>Conclusions: </strong>Testing a draft leaflet with the target population before final development and dissemination is a critical component of an educational outreach effort. Incorporating feedback can help enhance the quality of the end product.</p>","PeriodicalId":90142,"journal":{"name":"Clinical medicine insights. Women's health","volume":"4 ","pages":"17-33"},"PeriodicalIF":0.0,"publicationDate":"2011-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/CMWH.S6541","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32407521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
Clinical medicine insights. Women's health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1